CervoMed Inc. Increase (Decrease) in Other Accrued Liabilities
CervoMed Inc. (CRVO) reported Increase (Decrease) in Other Accrued Liabilities of $0 for the 12-month period ending 2013-12-31, per its 10-K/A filed 2014-04-23.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2014-04-23
- CervoMed Inc. increase (decrease) in other accrued liabilities for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. increase (decrease) in other accrued liabilities for the quarter ending 2012-12-31 was $808.60K.
- CervoMed Inc. increase (decrease) in other accrued liabilities for the quarter ending 2012-09-30 was $0.00.
- CervoMed Inc. increase (decrease) in other accrued liabilities for the quarter ending 2010-09-30 was $0.00.
- CervoMed Inc. increase (decrease) in other accrued liabilities for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- CervoMed Inc. increase (decrease) in other accrued liabilities for fiscal 2012 was $1.26M.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $0.00 10-K/A · filed 2014-04-23 | ||
| 2013-09-30 | $0.00 10-Q · filed 2013-11-19 | |||
| 2012-12-31 | $808.60K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $808.60K derived: sum of 2 quarters · filed 2014-04-23 | $1.26M 10-K/A · filed 2014-04-23 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $452.04K 10-Q · filed 2013-11-19 | ||
| 2012-06-30 | $452.04K 10-Q · filed 2013-08-14 | |||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | -$5.00K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | -$5.00K 10-Q · filed 2011-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |